Physicians should be alert while treating patients with SLE who develop a new apparent rheumatic presentation with a decreased SLE-specific autoantibody titer, positive anti-RNP antibodies, and elevated CPK. Here, PIK3C2A is linked to systemic lupus erythematosus.